Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.4/5
Huadong Medicine Co Ltd A (000963 CH)
Watchlist
57
Analysis
Health Care
•
China
Huadong Medicine Co., Ltd. wholesales and retails medicines, pharmaceutical preparations, biological products, and medical instruments. Through its subsidiaries, the Company also manufactures antibiotic medicines and biochemical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Imeik Technology Development C
•
19 Jul 2021 01:30
Imeik Technology Development (300896.CH) - The Valuation Bubble?
This insight mainly analyzed Imeik in terms of its hyaluronic acid product business, botulinum toxin business, other products, the future business...
Xinyao (Criss) Wang
Follow
355 Views
Share
bearish
•
Thematic (Sector/Industry)
•
20 Jun 2021 00:59
China Healthcare Weekly (Jun.18)
The article analyzed the 2021 medical insurance catalogue adjustment plan, new document to crack down on illegal medical beauty activities, new...
Xinyao (Criss) Wang
Follow
280 Views
Share
bearish
•
Thematic (Sector/Industry)
•
22 Feb 2021 01:28
China Healthcare Weekly (Feb.19) - VBP on Biosimilar Drugs, Poor Performance of Healthcare Sector
This article analyzed the new document about VBP for biosimilar drugs, diabetes drugs market, support devices market in interventional fields,...
Xinyao (Criss) Wang
Follow
361 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 Nov 2020 01:41
China Healthcare Weekly (Nov.6)
This article summarized the new healthcare policy released in China, major industry viewpoints, company news and capital markets review for the...
Xinyao (Criss) Wang
Follow
343 Views
Share
bearish
•
Kweichow Moutai
•
07 Oct 2019 06:43
Shanghai/​​Shenzhen Connect Ideas: Stalled Flows Ahead of Golden Week (2019-10-04)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
578 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x